BASEC ID Project title Type of project Type of clinical trial Study phase (clinical trials only) multi- / monocentric Category Principal investigator Sponsor Investigational sites Lead EC Local EC(s) Approval date Minors Study Ended
2020-02394 EFC16295 - A Phase 3 open-label, multicenter study of the safety, efficacy and pharmacokinetics of intravenous recombinant coagulation Factor VIII Fc-von Willebrand Factor-XTEN fusion protein (rFVIIIF More ... clinical trial drugs phase 3 monocentric C Prof. Dr. med. Manuela Albisetti Pedroni Bioverativ Therapeutics Inc. (a Sanofi Company) Universitäts-Kinderspital Zürich – Eleonorenstiftung, Zürich
Kantonale Ethikkommission Zürich 24.11.2020 yes Study has ended
2020-02393 GR41987 A MULTICENTER, OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND TOLERABILITY OF FARICIMAB IN PATIENTS WITH DIABETIC MACULAR EDEMA clinical trial drugs phase 3 monocentric C Dr. Katja Hatz Roche Pharma (Schweiz) AG Vistaklinik, Binningen
Ethikkommission Nordwest- und Zentralschweiz EKNZ 26.11.2020 Study has ended
2020-02392 Motor and non-motor outcomes of deep brain stimulation personal data/biological material monocentric Prof Paul Krack Inselspital Bern Inselspital, Bern
Kantonale Ethikkommission Bern 27.07.2021
2020-02391 A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared with Teriflunomide, in Participants with Relapsing Multiple Sclerosis More ... clinical trial drugs phase 3 multicentric C Prof. Dr. med. Chiara Zecca Merck Healthcare KGaA Ospedale Regionale di Lugano, Lugano
Inselspital, Universitätspital Bern, Bern
Kantonsspital Aarau, Aarau
Comitato etico cantonale Ticino Ethikkommission Nordwest- und Zentralschweiz EKNZ, Kantonale Ethikkommission Bern 19.01.2021 Study has ended
2020-02390 Cardiac function in patients with Duchenne Muscular Dystrophy treated with Tamoxifen compared to Placebo personal data/biological material monocentric Prof. Dr. med. Dirk Fischer Universitätskinderspital beider Basel (UKBB), Basel
Ethikkommission Nordwest- und Zentralschweiz EKNZ 19.10.2020
2020-02389 Postoperative complications at the Luzerner Kantonsspital personal data/biological material monocentric PD Dr. med. Christian Fankhauser Luzerner Kantonsspital, Klinik für Urologie Luzerner Kantosspital, Luzern
Ethikkommission Nordwest- und Zentralschweiz EKNZ 26.11.2020
2020-02388 Feasibility of technology-based cognitive-motor training in rehabilitation: A pilot-trial clinical trial other clinical trials multicentric A Prof. Eling D. de Bruin ETH Zurich ETH Zurich, Zurich
Rehaklinik Zihlschlacht, Zihlschlacht
Rehaklinik Dussnang, Dussnang
Rehaklinik Seewis, Seewis
Kantonale Ethikkommission Zürich Ethikkommission Ostschweiz (EKOS), Kantonale Ethikkommission Zürich 01.12.2020
2020-02387 Impact of gut microbiota and immune contexture on effectiveness of neo-adjuvant chemo-radiotherapy in locally advanced rectal cancer personal data/biological material multicentric Prof. Dr. med. D. Christoforidis EOC EOC Surgical Department, Lugano
Unità di ricerca clinica/Servizio di Radioterapia Clinica Luganese Moncucco, Lugano
Comitato etico cantonale Ticino Comitato etico cantonale Ticino 09.11.2020
2020-02386 The Lugano classification for diverticulitis non clinical, involving persons monocentric A Prof. Dr.med EOC Surgery Department EOC Surgery Department, Lugano
Comitato etico cantonale Ticino 29.10.2020 Study has ended
2020-02385 A Phase 3 Randomized, Double-blind, Multicenter, Global Study of Monalizumab or Placebo in Combination With Cetuximab in Participants With Recurrent or Metastatic Squamous Cell Carcinoma of the Head a More ... clinical trial drugs phase 3 multicentric C Dr. Petr Szturz AstraZeneca AB CHUV, Centre hospitalier universitaire vaudois, Lausanne
Inselspital Bern, Universitätsklinik für Medizinische Onkologie, Bern
Universitätsspital Basel - Klinik für Onkologie, Basel
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) Ethikkommission Nordwest- und Zentralschweiz EKNZ, Kantonale Ethikkommission Bern 09.03.2021 Study has ended
2020-02384 Transcantonal early detection and intervention in adolescents and young adults with high psychosis risk (PsyYoung) non clinical, involving persons multicentric A Christian Huber CHUV UPK Basel, Basel
Unité de psychiatrie du jeune adulte / HUG, Geneva
Service de Psychiatrie générale-DP/CHUV, Lausanne
Ethikkommission Nordwest- und Zentralschweiz EKNZ Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD), Commission Cantonale d'éthique de la recherche Genève (CCER) 08.02.2021 yes
2020-02383 Characterization of intestinal microbiota in children with inborn errors of metabolism (IEM) non clinical, involving persons monocentric A Prof. Dr. med. Johannes Häberle ETH Zürich Universitäts-Kinderspital, Zürich
Kantonale Ethikkommission Zürich 17.11.2020 yes Study has ended
2020-02381 Suivi clinique rétrospectif et prospectif des patients ayant bénéficié d’une fermeture percutanée de l’appendice auriculaire gauche non clinical, involving persons monocentric A Dr Stéphane Noble Service de Cardiologie Hôpitaux universitaires de Genève, Genève
Commission Cantonale d'éthique de la recherche Genève (CCER) 09.02.2021
2020-02380 Prevalence of enterococcal groin colonization in cardiological patients personal data/biological material monocentric PD Dr. med., MSc, Anna Conen Kantonsspital Aarau Kantonsspital Aarau, Aarau
Ethikkommission Nordwest- und Zentralschweiz EKNZ 23.10.2020 Study has ended
2020-02379 Validation de la stabilité inter-rater et intra-rater du codage du diagnostic des troubles cognitifs selon les critères de la Banque Nationale Alzheimer dans le Centre Leenaards de la Mémoire du CHUV. personal data/biological material monocentric Prof.Jean-françois Démonet Centre Leenaards de la mémoire Centre Leenaards de la mémoire, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 24.11.2020
2020-02378 Evaluation of the efficacy of Methylene Blue administration in SARS-CoV2- affected patients: a phase 2, randomized, placebo- controlled, single blind clinical trial clinical trial drugs phase 2 monocentric C Prof Dr Med Andreas Cerny Epatocentro Ticino Epatocentro Ticino, Lugano
Comitato etico cantonale Ticino 05.11.2020 Study has ended
2020-02377 Evaluation of Arm-level Alterations in Individual Cancer Patients personal data/biological material monocentric Dr Petros Tsantoulis Hôpitaux Universitaire de Genève Hôpitaux Universitaire de Genève, Genève
Commission Cantonale d'éthique de la recherche Genève (CCER) 21.12.2020 Study has ended
2020-02376 19225 ASSESS-CKD: A randomized, double-blind, placebo-controlled, multi-center study to assess the efficacy and safety of BAY 2327949 in patients with chronic kidney disease (eGFR range from 25 to 60 More ... clinical trial drugs phase 2 multicentric C PD Dr. med. Stefan Bilz Bayer (Schweiz) AG Kantonsspital St. Gallen, St. Gallen
Inselspital Bern, Bern
Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne
Ethikkommission Ostschweiz (EKOS) Kantonale Ethikkommission Bern, Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 23.11.2020 Study has ended
2020-02375 Phenotypic and molecular characterization of leukocytes in human bladder cancer non clinical, involving persons monocentric A Dr Petros Tsantoulis Université de genève Hôpitaux universitaire de Genève, Genève
Commission Cantonale d'éthique de la recherche Genève (CCER) 14.12.2020
2020-02373 Neural correlates of heartbeat and auditory processing in awake and sleeping individuals non clinical, involving persons multicentric A Dr Marzia De Lucia CHUV - EEG platform - LREN Lausanne University Hospital, Lausanne
Université de Genève, Genève
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) Commission Cantonale d'éthique de la recherche Genève (CCER) 25.11.2020